 | Is Galectin Therapeutics Inc. (GALT) A Good Stock To Buy?
finance.yahoo.com - June 13 at 11:31 PM |
 | -$0.18 EPS Expected for Galectin Therapeutics Inc. (NASDAQ:GALT) This Quarter
americanbankingnews.com - May 31 at 11:24 AM |
| Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2021, and Provides Business Update
finance.yahoo.com - May 17 at 8:30 AM |
| Galectin Therapeutics to Present at 4th Global NASH Congress
finance.yahoo.com - April 27 at 1:05 PM |
| World-Renowned Neurosurgeon Dr. Ben Carson, Sr. Joins Galectin Therapeutics as Special Consultant to Accelerate and Enhance Development of Company’s Galectin-3 Inhibitor, Belapectin
finance.yahoo.com - April 19 at 9:29 AM |
 | Have Insiders Been Selling Galectin Therapeutics Inc. (NASDAQ:GALT) Shares?
nasdaq.com - April 18 at 10:55 PM |
| Company News for Apr 15, 2021
finance.yahoo.com - April 15 at 12:45 PM |
 | What's Going On With GALT Stock And TV Stock Today?
benzinga.com - April 14 at 3:58 PM |
|
| Galectin Therapeutics Stock Is Trading Higher After Belapectin-Pembrolizumab Combo Study Shows Enhanced Tumor Response
finance.yahoo.com - April 14 at 3:58 PM |
 | Galectin Gains on Product News
baystreet.ca - April 14 at 10:58 AM |
| Journal for ImmunoTherapy of Cancer Publishes...
benzinga.com - April 14 at 12:56 AM |
| Journal for ImmunoTherapy of Cancer Publishes Phase 1 Clinical Research Showing Belapectin, Galectin Therapeutics’ Galectin-3 Inhibitor, Enhances Tumor Response in Combination with Anti-PD-1 Therapy
finance.yahoo.com - April 13 at 7:55 PM |
| Galectin Therapeutics Launches NAVIGATEnash.com, a Resource for Both Patients and Physicians about its Innovative NASH Cirrhosis Study
finance.yahoo.com - April 6 at 9:28 AM |
| Galectin Therapeutics Reports Fiscal 2020 Financial Results and Provides Business Update
finance.yahoo.com - March 31 at 1:01 PM |
| OncoImmunology Publishes Pre-clinical Research Showing Galectin Therapeutics’ Belapectin Galectin-3 Inhibitor Reduces Tumor Progression in Combination with Anti-OX40 Therapy
finance.yahoo.com - March 8 at 11:34 AM |
| Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 4 at 12:28 PM |
| Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 4 at 12:28 PM |
| What Kind Of Investors Own Most Of Galectin Therapeutics, Inc. (NASDAQ:GALT)?
finance.yahoo.com - January 31 at 9:00 AM |
| Insider Sells Galectin Therapeutics Stock
finance.yahoo.com - January 19 at 6:00 PM |
 | GALT Jan 2021 10.000 put
uk.finance.yahoo.com - January 1 at 11:21 PM |
| Galectin Therapeutics Inc. Common Stock (GALT)
nasdaq.com - December 18 at 9:18 PM |
| Galectin Therapeutics, Inc. to Present at the 4th Annual Digital NASH Summit on December 17, 2020
finance.yahoo.com - December 11 at 8:19 AM |
| Galectin Therapeutics Inc. Recaps Results of Annual Meeting of Stockholders Presentation
finance.yahoo.com - December 4 at 5:55 PM |
| Galectin Therapeutics to Webcast Corporate Update on December 3, 2020 after Annual Meeting of Stockholders
finance.yahoo.com - December 1 at 5:10 PM |
| GALT Dec 2020 4.000 call
uk.finance.yahoo.com - November 29 at 2:43 AM |
| GALT Dec 2020 5.000 call
uk.finance.yahoo.com - November 27 at 3:17 PM |
| Galectin Therapeutics Provides Business Update And Reports Financial Results for the Quarter Ended September 30, 2020
finance.yahoo.com - November 9 at 12:38 PM |
| GALT Nov 2020 2.000 call
uk.finance.yahoo.com - November 2 at 2:36 PM |
|
| GALT Nov 2020 3.000 call
uk.finance.yahoo.com - November 2 at 9:35 AM |
| Galectin Therapeutics (NASDAQ:GALT) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - November 2 at 9:35 AM |
| GALT Nov 2020 1.000 call
uk.finance.yahoo.com - November 1 at 11:32 PM |
 | Galectin Therapeutics Investor Conference Call and Webinar Taking Place Today
markets.businessinsider.com - September 29 at 12:27 PM |
 | Galectin Therapeutics
fool.com - September 16 at 7:54 PM |
| Galectin Therapeutics Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020
finance.yahoo.com - September 10 at 11:17 AM |
| Insider Buys Galectin Therapeutics Stock
finance.yahoo.com - September 9 at 2:56 PM |
| GALT Aug 2020 3.000 call
ca.finance.yahoo.com - August 22 at 7:32 AM |
| GALT Jan 2021 5.000 call
ca.finance.yahoo.com - August 20 at 8:14 AM |
| GALT Aug 2020 2.000 call
ca.finance.yahoo.com - August 19 at 9:51 AM |
| GALT Sep 2020 3.000 call
ca.finance.yahoo.com - August 19 at 9:50 AM |
| Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2020, and Provides Business Update
finance.yahoo.com - August 10 at 12:38 PM |
| Is Galectin Therapeutics, Inc.'s (NASDAQ:GALT) Shareholder Ownership Skewed Towards Insiders?
finance.yahoo.com - August 3 at 1:21 PM |
| Galectin Therapeutics (GALT) Stock
markets.businessinsider.com - July 17 at 9:12 AM |
 | Intercept's Pain Is Galectin's Gain: Clinical Outcomes In NASH Are Crucial
seekingalpha.com - July 7 at 9:35 AM |
 | Galectin Therapeutics, Inc. and Providence Cancer Institute Receive Patent on the Use of Belapectin (GR-MD-02) in Cancer
www.bloomberg.com - July 6 at 11:33 PM |
| Galectin launches new study of lead drug in NASH
seekingalpha.com - June 30 at 1:18 PM |
| Galectin Therapeutics Announces Commencement of Patient Enrollment of the Adaptively-Designed Phase 2b/3 Trial of Belapectin in NASH Cirrhosis
finance.yahoo.com - June 30 at 1:18 PM |
| UPDATE -- Galectin Therapeutics Announces Commencement of Patient Enrollment of the Adaptively-Designed Phase 2b/3 Trial of Belapectin in NASH Cirrhosis
finance.yahoo.com - June 30 at 1:18 PM |
| Galectin Therapeutics' Shares March Higher, Can It Continue?
finance.yahoo.com - May 22 at 12:37 PM |
| GALT Galectin Therapeutics Inc. Common Stock
www.nasdaq.com - May 20 at 11:43 PM |
| Galectin Therapeutics EPS beats by $0.03
seekingalpha.com - May 11 at 5:29 PM |
